A survey of outpatient management of elderly heart failure patients in Poland - Treatment patterns

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 177-184

  Rywik, Tomasz M ^a   Rywik, Stefan L ^b   Korewicki, Jerzy ^a   Broda, Grazyna ^b   Sarnecka, Aleksandra ^c   Drewla, Joanna ^c  

^a Heart Failure Department   (Poland)

^b Servier Polska ^*  (Poland)

^c Servier Cardiovascular   (Poland)

Author keywords

Heart failure; Out patient clinics; Pharmacotherapy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE;

AMBULATORY CARE; DRUG USE; HEALTH SURVEY; HEART FAILURE; HUMAN; OUTPATIENT CARE; POLAND; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 2942604718     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.04.027     Document Type: Article

References (59)

1. Mc Govern P.G., Pankow J.S., Shahar E., Doliszny K.M., Folsom A.R., Blackburn H., et al. Recent trends in acute coronary heart disease. Mortality, morbidity, medical care, risk factors. N. Engl. J. Med. 334:1996;884-890
2. Senni M., Tribouilloy C.M., Rodeheffer R.J., Jacobsen S.J., Evans J.M., Bailey K.R., et al. Congestive heart failure in the community. A study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 98:1998;2282-2289
3. Zannad F., Briancon S., Juilliere Y., Mertes P.M., Villemont J.P., Alla F., et al. Incidence, clinical and etiological features and outcomes of advanced chronic heart failure: the EPICAl study. J. Am. Coll. Cardiol. 33:1999;734-742
4. Ho K.L., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after the onset of congestive heart failure in framingham heart study subjects. Circulation. 88:1993;107-115
5. Tavazzi L. Epidemiological burden of heart failure. Heart. 79(Suppl. 2):1998;56-59
6. Cleland G.F., Clark A. Has the survival of heart failure population changed? Lessons from trials. Am. J. Cardiol. 83:1999;112D-119D
7. Working group on heart failure initiatives Increasing awareness and improving the management of heart failure in Europe: the IMPROVEMENT of HF initiative. Eur. J. Heart Fail. 1:1999;139-144
8. CIBIS II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study (Cibis II) A randomised trial. Lancet. 353:1999;9-13
9. The consensus Trial Group Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian Enalapril Survival Study. N. Engl. J. Med. 316:1987;1429-1435
10. The Solvd Investigators Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N. Engl. J. Med. 327:1992;685-691
11. The Digitalis Investigation Group The effect of digoxin on mortality in patients with heart failure. N. Engl. J. Med. 336(7):1997;525-533
12. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342:2000;145-153
13. The CAPRICORN Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 357:2001;1385-1390
14. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 283(10):2000;1295-1302
15. Consensus recommendation for the management of chronic heart failure, M. Packer, J.W. Cohn (Eds.), W.T. Abraham, W.S. Coluci, M.B. Fowler, B.H. Greenberg, C.V. Leier, B.M. Massie, J.B. Young (Co-eds.); Am. J. Cardiol. 83 (1999) (Suppl. 2A) 2A-38A.
16. The Task Force for the diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology, Remme W.J., Swedberg K. Guidelines for the Diagnosis and Treatment of Chronic Heart Failure. Eur. Heart. J. 22:2001;1527-1560
17. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adults: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). JACC. 38(7):2001;2101-2113
18. Rywik S.L., Wagrowska H., Broda G., Sarnecka A., Pytlak A., Polakowska M., et al. Heart failure in patients seeking medical help at outpatient clinics: Part I. General characteristics. Eur. J. Heart Fail. 2:2000;413-421
19. Cleland J.G., Swedberg K., Cohen-Solal A., Cosin-Aguilar J., Dietz R., Follath F., et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur. J. Heart Fail. 2(2):2000 (Jun);123-132
20. McAlister F.A., Teo K.K., Taher M., Montague T.J., Humen D., Cheung L., et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am. Heart J. 138:1999;87-94
21. Philbin E.F. Factors determining angiotensin-converting enzyme inhibitors underutilizations in heart failure in a community setting. Clin. Cardiol. 21:1998;103-108
22. Gattis W.A., Larsen R.L., Hasselblad V., Bart B.A., O'Connor C.M. Is optimal angiotensin converting enzyme inhibitor neglected in elderly patients with heart failure. Am. Heart J. 136:1998;43-48
23. Reis S.E., Holubkov R., Edmundowicz S.D., McNamara D.M., Zell K.A., Detre K.M., et al. Treatment of patients admitted to hospital with congestive heart failure: specialty related disparities in practice patterns and outcomes. J. Am. Coll. Cardiol. 30:1997;733-738
24. Cleland J.G.F., Swedberg K., Poole-Wilson P.A. Successes and failures of current treatment of heart failure. Lancet. 352:1998;19-28
25. Smith N.L., Psaty B.M., Pitt B., Garg R., Gottdiener J.S., Heckbert S.R. Temporal patterns in the medical treatment of congestive heart failure with angiotensin converting enzyme inhibitors in older adults, 1989 through 1995. Arch. Intern. Med. 158:1998;1074-1080
26. Pitt B., Segal R., Martinez F.A., Meurers G., Cowleyy A.J., Thomas I., et al. Randomised trial of losartan vs. captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly, ELITE). Lancet. 349:1997;747-752
27. Garg R., Yusuf S. Overview of randomized trials with angiotensin- converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 273:1995;1450-1456
28. Trandolapril Cardiac Evaluation (TRACE) Study Group Effects on mortality by trandolapril after myocardial infarction. N. Engl. J. Med. 333:1995;1670-1676
29. The Acute Infaction Ramipril Efficacy (AIRE) Study Investigators Effects of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828
30. Wilson J.R., Reichek N., Dunkman W.B., Goldberg S. Effect of diuresis on the performance of the failing left ventricle in man. Am. J. Med. 70:1981;234-239
31. Parker J.O. The effects of oral ibopamine in patients with mild heart failure: a double blind placebo controlled comparison to furosemide. Int. J. Cardiol. 40:1993;221-227
32. Richardson A., Bayliss J., Scriven A.J., Parameshawar J., Poole-Wislon P.A., Sutton G.C. Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure. Lancet. 2:1987;709-711
33. The Captopril-Digoxin Multicenter Research Group Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. JAMA. 259:1988;539-544
34. Gheorghiade M., Cody R.J., Francis G.S., McKenna W.J., Young J.B., Bonow R.O. Current medical therapy for advanced heart failure. Am. Heart J. 135(6):1998;231-248. Part 2
35. Vasan R.S., Larson M.G., Benjamin E.J., Reiss C.K., Levy D. Congestive heart failure in subjects with normal vs. reduced left ventricular ejection fraction: prevalence and mortality in a population based cohort. J. Am. Coll. Cardiol. 33(7):1999;1948-1955
36. Krum H., Bigger J.T., Packer M. Effect of long term digoxin therapy on an autonomic function in patients with chronic heart failure. J. Am. Coll. Cardiol. 25:1995;289-294
37. Norwegian Multicenter Study Group Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med. 304:1981;1115-1122
38. Beta Blocker Heart Attack Study Group A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results. JAMA. 247:1982;1707-1714
39. Packer M. Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failure. Circulation. 80(Suppl. IV):1989;IV59-IV67
40. Packer M. Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy. Circulation. 82(6):1990;2254-2257
41. The Multicenter Diltiazem Postinfarction Trials Research Group The effect of diltiazem on mortality and reinfarction after myocardial infarction. N. Engl. J. Med. 319:1988;385-393
42. Elkayam U., Amin J., Mehra A., Weber L., Rahimtoola S.H. A prospective randomized double-blind, cross-over study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of congestive heart failure. Circulation. 82:1990;1954-1961
43. Benatar D., Hall V., Reddy S., Gheorghiade M. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy. Am. J. Ther. 52:1998;25-32
44. Packer M., O'Connor C.M., Ghali J.K., Pressler M.I., Carson P.E., Belkin R.N., et al. For the prospective Randomized Amlodipine Survival Evaluation Study Group Effect of amlodipine on morbidity and mortality in severe heart failure. N. Engl. J. Med. 335:1996;1107-1114
45. Cohn J.N., Ziesche S., Smith R., Annad I., Dunkan W.B., Loeb H., et al. Effect of the calcium antagonists felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril. V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 96:1997;856-863
46. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomize Amlodipine Survival Evaluation Study Group. N. Engl. J. Med. 335:1996;1110-1114
47. Parker M. Prospective randomized amlodipine survival evaluation (PRAISE-2). J. Amer. Coll. Cardiol. 36(1):2000;322-323
48. Thackray S., Witte K., Clark A.L., Cleland J.G. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT. Eur. J. Heart Fail. 1:1999;209-212
49. Pahor M., Psaty B.M., Alderman M.H., Applegate W.B., Williamson J.D., Cavazzi C., et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised clinical trials. Lancet. 356:2000;1949-1953
50. Crawford, Di Marco Heart Failure with Normal Left Ventricular Ejection Fraction: A Manifestation of Diastolic Dysfunction. Cardiology Textbook. 2001
51. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines subcommittee Hypertension. 17(2):1999;151-183
52. Lewis B.S., Rabinowitz B., Schlesinger Z., Caspi A., Markiewicz W., Rosenfeld Y.T., et al. Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study. Cardiology. 91(1):1999;1-7
53. Elkayam U., Johnson J.V., Shotan A., Bokhari S., Solodky A., Canetti M., et al. Double-blind, placebo controlled study to evaluate the effect of organic nitrates in patients with chornic heart failure treated with angiotensin-converting enzyme inhibition. Circulation. 99(20):1999;2652-2657
54. Franciosa J.A., Nordstrom L.A., Cohn J.N. Nitrate therapy for congestive heart failure. JAMA. 240(5):1978;443-446
55. Crawford, Di Marco Congestive Heart Failure - Management of Patients with Chronic Heart Failure. Cardiology Textbook. 2001
56. Nakamura Y., Moss A.J., Brown M.W., Kinoshita M., Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am. Heart J. 138(3 Pt. 1):1999;577-585
57. Ishikawa K., Kanamasa K., Ogawa I., Takenaka T., Naito T., Kamata N., et al. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn. Circ. J. 60(10):1996;779-788
58. Marantz R.R., Tobin J.N., Wasserheil-Smoller R., et al. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation. 77:1988;607-612
59. Carlson K.J., Lee D.C., Goroll A.H., et al. An analysis of physicians reasons for prescribing long term digitalis in outpatients. J. Clin. Dis. 38:1985;733-739